Xvivo Perfusion AB (publ) (0RKL.L)

SEK 461.69

(1.25%)

Long Term Debt Summary of Xvivo Perfusion AB (publ)

  • Xvivo Perfusion AB (publ)'s latest annual long term debt in 2023 was 21.16 Million SEK , up 375.17% from previous year.
  • Xvivo Perfusion AB (publ)'s latest quarterly long term debt in 2024 Q3 was - SEK , down 0.0% from previous quarter.
  • Xvivo Perfusion AB (publ) reported annual long term debt of 4.45 Million SEK in 2022, up 192.71% from previous year.
  • Xvivo Perfusion AB (publ) reported annual long term debt of 1.52 Million SEK in 2021, down -53.68% from previous year.
  • Xvivo Perfusion AB (publ) reported quarterly long term debt of 19.91 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • Xvivo Perfusion AB (publ) reported quarterly long term debt of 17.12 Million SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Xvivo Perfusion AB (publ) (2023 - 2012)

Historical Annual Long Term Debt of Xvivo Perfusion AB (publ) (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 21.16 Million SEK 375.17%
2022 4.45 Million SEK 192.71%
2021 1.52 Million SEK -53.68%
2020 3.28 Million SEK 52.55%
2019 2.15 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%

Peer Long Term Debt Comparison of Xvivo Perfusion AB (publ)

Name Long Term Debt Long Term Debt Difference